Search

Your search keyword '"Huey, Edward D."' showing total 61 results

Search Constraints

Start Over You searched for: Author "Huey, Edward D." Remove constraint Author: "Huey, Edward D." Database OAIster Remove constraint Database: OAIster
61 results on '"Huey, Edward D."'

Search Results

1. Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum

2. Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research.

3. Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders.

4. Proposed research criteria for prodromal behavioural variant frontotemporal dementia.

5. Differences in Motor Features of C9orf72, MAPT, or GRN Variant Carriers With Familial Frontotemporal Lobar Degeneration.

6. Proposed research criteria for prodromal behavioural variant frontotemporal dementia.

7. Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders.

8. The contribution of behavioral features to caregiver burden in FTLD spectrum disorders.

9. Brain volumetric deficits in MAPT mutation carriers: a multisite study.

10. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.

11. Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia.

12. Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia.

13. Presymptomatic and symptomatic MAPT mutation carriers feature functional connectivity alterations

14. The contribution of behavioral features to caregiver burden in FTLD spectrum disorders.

15. Demographic and psychosocial factors associated with the decision to learn mutation status in familial frontotemporal dementia and the impact of disclosure on mood

16. Presymptomatic and symptomatic MAPT mutation carriers feature functional connectivity alterations

17. Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia.

18. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.

19. Brain volumetric deficits in MAPT mutation carriers: a multisite study.

20. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

21. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

22. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.

23. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

24. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

25. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.

26. New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.

27. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration.

28. Plasma neurofilament light chain levels reflect caregiver burden and social cognition measures in familial frontotemporal lobar degeneration (FTLD)

29. Plasma neurofilament light chain levels reflect caregiver burden and social cognition measures in familial frontotemporal lobar degeneration (FTLD)

30. New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.

31. Plasma neurofilament light chain levels reflect caregiver burden and social cognition measures in familial frontotemporal lobar degeneration (FTLD)

32. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.

33. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration.

34. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

35. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.

36. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

37. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

38. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

39. Nonlinear Z-score modeling for improved detection of cognitive abnormality.

40. P2-314: THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS

41. P2-314: THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS

42. Nonlinear Z-score modeling for improved detection of cognitive abnormality.

43. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

44. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.

45. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.

46. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

47. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations:a genome-wide association study

48. [P2–303]: ADVANCING RESEARCH AND TREATMENT IN FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) NORTH AMERICAN RARE DISEASE CLINICAL RESEARCH CONSORTIUM: PROGRESS AND CHARACTERIZATION OF INITIAL PARTICIPANTS

49. Differential medial temporal lobe morphometric predictors of item- and relational-encoded memories in healthy individuals and in individuals with mild cognitive impairment and Alzheimer's disease.

50. [P2–303]: ADVANCING RESEARCH AND TREATMENT IN FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) NORTH AMERICAN RARE DISEASE CLINICAL RESEARCH CONSORTIUM: PROGRESS AND CHARACTERIZATION OF INITIAL PARTICIPANTS

Catalog

Books, media, physical & digital resources